Objective: To show the effectiveness of the indocyanine green application in laparoscopic cholecystectomy of any complexity.
Material And Methods: Our study used a domestically produced drug, namely indocyanine green, lyophilisate, which was diluted in water for injections. In addition, 4K equipment with the possibility of fluorescence of different manufacturers (Arthrex, ELEPS, KARL STORZ) was used.
Khirurgiia (Mosk)
August 2024
Objective: To assess the safety and effectiveness of the indocyanine green use in acute cholecystitis for identification of anatomical variants of the biliary tree; prevention and timely detection of intraoperative complications.
Material And Methods: The medication of indocyanine green made by OOO «Ferment» domestic manufacturer was used. The drug dose from 2.
Aim: To determine the density of densitometric gallstones and biliary sludge in order to clarify the possibility of lithotherapy in patients with gallstone disease (GSD).
Materials And Methods: 70 patients were carried out a comprehensive clinical examination with determination of densitometric density of gallstones and/or biliary sludge by means of computer tomography (CT), ultrasound of the abdomen, biochemical blood analysis. Assigned to the complex lithotherapy (Ursofalk and Kholit) in standard dosages, the results were evaluated in a year.
Pneumoencephalography was performed in 35 patients with a significant diagnosis of disseminated sclerosis. Enlargement of the III ventricle was revealed in 21 patients (60%), dropsy of lateral ventricles in 16 (45,6%) and that of the IV ventricle in 13 (37,2%), atrophy of brain stem in 9 (25,4%), block of the subarachnoidal space in 11 patients (31,4%). The most pronounced brain changes were seen in patients with a cerebellar form of disseminated sclerosis and in those having severe motor disturbances, ataxia and tremor.
View Article and Find Full Text PDFZh Nevropatol Psikhiatr Im S S Korsakova
October 1984
In 42 patients with cervical sympathicoganglionitis and secondary diencephalic dysfunction, the cerebral circulation was studied by REG in order to elucidate the role of vascular factor in the pathogenesis of diencephalic impairments. The authors established the persistent elevation in the tone of the cerebral vessels in the carotid and vertebral-basilar area and a decrease in the pulse blood filling. The nitroglycerin test indicated the functional nature of the changes.
View Article and Find Full Text PDFZh Nevropatol Psikhiatr Im S S Korsakova
July 1983
Novel concepts of both the pathogenesis of secondary trunko-hypothalamic dysfunctions ("repercussive diencephaleses") associated with sympathoganglionites and their pathogenetic therapy are offered. They are based on new fundamental data concerning the physiology of vegetative ganglia, as well as on the findings of the clinical and electroencephalographic examinations, and the results of treatment of 67 patients with cervical sympathoganglionites. The suggested method of pathogenetic therapy consists of pharmacologically-induced blocking of the pathological afferent impulsation from the affected sympathetic ganglion; which is achieved by mild solutions of ganglioblockers administered into the ganglion; which is achieved by mild solutions of ganglioblockers administered into the ganglion by graded electrophoresis.
View Article and Find Full Text PDFZh Nevropatol Psikhiatr Im S S Korsakova
September 1976
A long-term observation over patients with disseminated scleosis who were treated by glucorticoid hormones demonstrated that hormone therapy with short sessions and a standard scheme appeared to be uneffective. The presentation is based on an examination of 25 patients who had undergone a durative course of hormone therapy with an individual scheme of optimal doses equal to middle ones (30-40 mg of prednisolon) and a selection of maintenance doses used for a long time or with short intervals. Such forms of treatment were more effective.
View Article and Find Full Text PDFZh Nevropatol Psikhiatr Im S S Korsakova
January 1975
Zh Nevropatol Psikhiatr Im S S Korsakova
May 1975
Zh Nevropatol Psikhiatr Im S S Korsakova
November 1975
Zh Nevropatol Psikhiatr Im S S Korsakova
July 1972
Zh Nevropatol Psikhiatr Im S S Korsakova
May 1970
Zh Nevropatol Psikhiatr Im S S Korsakova
March 1970
Zh Nevropatol Psikhiatr Im S S Korsakova
February 1969
Zh Nevropatol Psikhiatr Im S S Korsakova
October 1968